What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Bristol-Myers Squibb
92%DGNews: FDA Antiviral Advisory Committee Recommends Approval For Investigational Protease Inhibitor Reyataz (Atazanavir)
92%DGNews: New Collaboration in Developing Drug for Parkinson's Disease
92%DGNews: Broad-Spectrum Antifungal Licensed by Bristol-Myers Squibb
92%DGNews: Expanded labelling requested for Zerit
91%DGNews: Bristol-Myers Squibb Announces Discontinuation of Development of Muraglitazar, an Investigational Oral Treatment for Type 2 Diabetes
91%DGNews: New Treatment Option for Second Leading Cause of Cancer Deaths in Canada, Health Canada Approves Erbitux (Cetuximab) for the Treatment of Metastatic Colorectal Cancer
91%DGNews: U.S. Food and Drug Administration Approves Pravachol (Pravastatin Sodium) for Use in Pediatric Patients
91%DGNews: Bristol-Myers Squibb Receives FDA Approval Of Metaglip (Glipizide/ Metformin HCl Tablets) For Type 2 Diabetes
91%DGNews: Bristol-Myers Squibb Acquires Exclusive Rights to the COMPASS System
91%DGNews: Zerit Cleared Under FDA Accelerated Approval Regulations
91%DGNews: Zerit (stavudine) Approved For First-Line Treatment of HIV in Europe
90%DGNews: FDA Approves Pravigard PAC (Buffered Aspirin and Pravastatin Sodium) Tablets For Those At Risk Of Heart Disease, Heart Attack, Or Stroke
90%DGNews: ASCO: BMS-247550 Demonstrates Activity In Metastatic Breast And Non-Small Cell Lung Cancers
90%DGNews: FDA Approves Avapro (Irbesartan) For The Treatment Of Diabetic Nephropathy (Kidney Disease) In Patients With High Blood Pressure And Type 2 Diabetes
90%DGNews: Tequin Approved By FDA, Available By Year End
90%DGNews: Phase III Program On Trandermal Buspirone Patch Initiated
90%DGNews: FDA Approval Sought For Once-Daily Glucophage For Type 2 Diabetes
90%DGNews: Zerit for HIV/AIDS to be Reimbursed by Ontario Government
90%DGNews: Zerit for HIV/AIDS to be Reimbursed by Quebec Government
89%DGNews: FDA Approves Reyataz(R) (Atazanavir Sulfate) 300 mg Single Capsule Formulation in Combination Therapy for Adults With HIV-1 Infection
89%DGNews: Bristol-Myers Squibb Submits New Drug Application for Dasatinib
89%DGNews: First Single-Tablet, Once-Daily Non-Nucleoside Reverse Transcriptase Inhibitor Sustiva 600 Available in UK
89%DGNews: FDA Approves One Tablet/Once Daily Formulation of Sustiva (Efavirenz) for HIV
89%DGNews: FDA Approves Glucophage XR (Metformin) Extended Release Formulation For Type 2 Diabetes
89%DGNews: Agreement With NCI for Extended Collaborative Research of Taxol
88%DGNews: Important Safety Information Released on Definity(R) (Perflutren Injectable Suspension) and Serious Cardiopulmonary Reactions
88%DGNews: CPMP Recommends Granting Marketing Authorization in the European Union For Plavix/Iscover (clopidogrel) for the Treatment of Acute Coronary Syndrome with Non ST Segment Elevation
88%DGNews: European Commission Approves Irbesartan (Aprovel/Karvea) for the Treatment of Diabetic Renal Disease
88%DGNews: Results Published Demonstrate that Irbesartan Provides Greater Blood Pressure Reduction than Valsartan in Patients with Elevated Blood Pressure
88%DGNews: FDA Approves Pravachol (Pravastatin) 80 mg for Heart Disease
88%DGNews: IDSA: Experimental Quinolone Cures Almost all Patients with Acute Bacterial Maxillary Sinusitis
88%DGNews: Ceretec New Alzheimer's Diagnostic Agent Now Available
88%DGNews: FDA Approves Shorter Regimen For Cancer Drug Taxol (Paclitaxel)
88%DGNews: FDA Approves Glucovance (Glyburide And Metformin) For Type 2 Diabetes
88%DGNews: OTC VAGISTAT-1 Treatment for Vaginal Yeast Infections Cleared by FDA
88%DGNews: Voluntary Limited Recall of Ovcon 35 by Bristol-Myers Squibb
88%DGNews: Clopidogrel Receives European Marketing Approval For Atherosclerotic Events
88%DGNews: ZERIT, an Important New Option for Treating HIV-Infected Children
88%DGNews: APA MEETING: Drug-Psychotherapy Combo Effective For Chronic Depression
87%DGNews: FDA Approves Ixabepilone for the Treatment of Advanced Breast Cancer
87%DGNews: Medarex Announces FDA Fast Track Designations for Ipilimumab for the Treatment of Metastatic Melanoma
87%DGNews: Baxter Launches Mesnex (Mesna) Tablets
87%DGNews: CINP: Aripiprazole Delays Relapse in Patients with Chronic Schizophrenia
87%DGNews: FDA Approves Tequin (Gatifloxacin) For Short Course Treatment of Acute Bacterial Exacerbation Of Chronic Bronchitis
87%DGNews: DG DISPATCH - ICDT-HIV: Once Daily Azapeptide Protease Inhibitor As Effective As Viracept (Nelfinavir) Three Times Daily
87%DGNews: Videx Prolongs Lives and Dramatically Delays Progression of AIDS
87%DGNews: Bristol-Myers Squibb Supports Three Major Clinical Studies For TaxolŽ
87%DGNews: Thalidomide Clinical Trials Expanded
86%DGNews: ACCP: Researchers Investigate Headaches Caused By New Drug, BMS-207940
86%DGNews: Data From Cohort Study Showed Better Virologic Response in Regimens Containing SUSTIVA(R) Compared to Viramune(R)-Containing Regimens in HIV Treatment-Naive Patients
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.